2023
DOI: 10.1007/s00270-023-03510-1
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes of Intravascular Lithotripsy in the Treatment of Chronic Limb-Threatening Ischemia: A Single-Center Retrospective Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Disadvantages include challenges in reimbursement and added cost, though cost-effectiveness analyses compared to open CFA revascularisation have not been performed yet. Long-term data are lacking to date [ 49 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ].…”
Section: Narrative Reviewmentioning
confidence: 99%
See 2 more Smart Citations
“…Disadvantages include challenges in reimbursement and added cost, though cost-effectiveness analyses compared to open CFA revascularisation have not been performed yet. Long-term data are lacking to date [ 49 , 52 , 53 , 54 , 55 , 56 , 57 , 58 ].…”
Section: Narrative Reviewmentioning
confidence: 99%
“…The DISRUPT PAD III trial has disclosed the distribution and further analysis of treated peripheral arteries, showing that the CFA was treated in 27 patients with different adjunctive therapies. Further subgroup analysis could be conducted for the DISRUPT PAD III trial and the data set from Salazar et al [ 54 , 56 ]. A prospective, multicentre, single-arm trial (FESTIVAL, NCT05821829) and another single-arm trial (CRUSH PAD) have been recruiting patients for CFA endovascular repair via lithotripsy to evaluate short-term safety and efficacy.…”
Section: Narrative Reviewmentioning
confidence: 99%
See 1 more Smart Citation